{{Rsnum
|rsid=37439
|Gene=DNAJC21
|Chromosome=5
|position=34951045
|Orientation=plus
|GMAF=0.3444
|Gene_s=DNAJC21
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 69.0 | 26.5 | 4.4
| HCB | 30.7 | 46.7 | 22.6
| JPT | 29.2 | 56.6 | 14.2
| YRI | 25.2 | 44.2 | 30.6
| ASW | 42.1 | 29.8 | 28.1
| CHB | 30.7 | 46.7 | 22.6
| CHD | 31.2 | 46.8 | 22.0
| GIH | 42.6 | 49.5 | 7.9
| LWK | 12.7 | 50.0 | 37.3
| MEX | 53.4 | 41.4 | 5.2
| MKK | 31.4 | 47.4 | 21.2
| TSI | 74.5 | 23.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22566498
|Trait=None
|Title=Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|RiskAllele=A
|Pval=0.000009
|OR=1.0000
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}